Charles A. Rowland Jr.
Chief Financial Officer, ENDO HEALTH SOLUTIONS INC.
Companies
- Generation Bio Co.Board member Jun 11, 2020 to now1
- Viking TherapeuticsBoard member Jul 5, 2017 to now2
- Orchard TherapeuticsBoard member Jan 2, 2020 to Jan 24, 20243
- Nabriva Therapeutics plcBoard member Dec 30, 2016 to Aug 3, 20224
- Blueprint Medicines CorpBoard member Apr 30, 2015 to Jun 4, 20215
- ViroPharmaChief financial officer Oct 21, 2008 to Jan 28, 20146
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Viking Therapeutics VKTX33,150 shares7$832.4K at $25.11Jan 2, 2026
- Nabriva Therapeutics plc15,277 shares8Aug 1, 2022
- Generation Bio Co.0 shares9Feb 9, 2026
- Orchard Therapeutics ORTX0 shares10Jan 24, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 9, 2026U 53,475 shares of Generation Bio Co.9
- Jan 2, 2026Granted 3,150 shares of Viking Therapeutics7
- Oct 27, 2025Sold 60,000 shares at $35.57 of Viking Therapeutics11
- Oct 27, 2025Granted 22,000 shares at $4.88 of Viking Therapeutics11
- Oct 27, 2025Granted 22,000 shares at $5.80 of Viking Therapeutics11
- Oct 27, 2025Granted 16,000 shares at $4.48 of Viking Therapeutics11
- Jan 24, 2024Returned to company 12,294 shares of Orchard Therapeutics10
- Dec 4, 2023Bought 150,000 shares at $1.50 of Generation Bio Co.12
- Dec 1, 2023Bought 192,960 shares at $1.31 of Generation Bio Co.12
- May 16, 2023Sold 40,000 shares at $25.00 of Viking Therapeutics13
- May 16, 2023Exercised options 40,000 shares at $1.08 of Viking Therapeutics13
- Sep 19, 2022Bought 15,750 shares at $5.26 of Generation Bio Co.14
- Sep 16, 2022Bought 33,481 shares at $5.48 of Generation Bio Co.15
- Sep 15, 2022Bought 17,147 shares at $5.41 of Generation Bio Co.15
- Sep 14, 2022Bought 5,600 shares at $5.30 of Generation Bio Co.16
- Sep 13, 2022Bought 18,784 shares at $5.20 of Generation Bio Co.16
- Aug 1, 2022Sold 8,496 shares at $0.18 of Nabriva Therapeutics plc8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARGeneration Bio Co., Board member
- 2SEC EDGARViking Therapeutics, Board member
- 3SEC EDGAROrchard Therapeutics, Board member
- 4
- 5
- 6SEC EDGARViroPharma, Chief financial officer
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Oct 28, 2025
- 12SEC EDGARForm 4 filed Dec 5, 2023
- 13SEC EDGARForm 4 filed May 18, 2023
- 14SEC EDGARForm 4 filed Sep 20, 2022
- 15SEC EDGARForm 4 filed Sep 19, 2022
- 16SEC EDGARForm 4 filed Sep 15, 2022